Skip to content

Clinical trials

Phase 3 Blood Protein Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Protein Disorders Phase: Phase 3 Country / region: France Clear all

1 trial matches Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Neoplasms1
Fractures, Bone1
Hematologic Diseases1
Hematologic Neoplasms1
Multiple Myeloma1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 1 of 1. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.